<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="107683">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02040363</url>
  </required_header>
  <id_info>
    <org_study_id>UF 9224</org_study_id>
    <nct_id>NCT02040363</nct_id>
  </id_info>
  <brief_title>Muscle Training Induced Angiogenesis in COPD</brief_title>
  <acronym>COPDµvasc</acronym>
  <official_title>Impact of Different Training Modalities on Skeletal Muscle Angiogenic Response in COPD Patients - COPDµvasc Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Université Montpellier</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Groupe Fontalvie</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      COPD patients experiment a peripheral muscle dysfunction which impact their exercise
      tolerance and health-related quality of life. The capillary to fiber interface is reduced
      and impact the exercise capacity of the patients. While exercise training induce a
      physiological angiogenesis, we have recently observed that there was a blunted muscle
      angiogenesis after training in COPD patients. This could be the consequence a an inadequate
      training duration or intensity. Aim of the study: Compare the muscle micro-vascular response
      to training (capillary-to-fiber ratio) at 5 and 10 weeks, in sedentary healthy subject
      trained at the intensity of the ventilatory threshold (60-65% of VO2max), versus :- COPD
      patients trained at a similar intensity (60-65% of VO2max)- COPD patients trained at a
      similar absolute intensity (90% of VO2max).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>Capillary-o-fiber ratio assessed by immunochemistry on a muscle biopsy of the vastus lateralis of the quadriceps</measure>
    <time_frame>5 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Capillary-o-fiber ratio assessed by immunochemistry on a muscle biopsy of the vastus lateralis of the quadriceps</measure>
    <time_frame>10 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>quadriceps endurance</measure>
    <time_frame>5 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mitochondrial density</measure>
    <time_frame>5 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>muscle citrate synthase activity</measure>
    <time_frame>5 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>quadriceps endurance</measure>
    <time_frame>10 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mitochondrial density</measure>
    <time_frame>10 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>muscle citrate synthase activity</measure>
    <time_frame>10 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Peripheral Muscle Dysfunction</condition>
  <condition>COPD</condition>
  <arm_group>
    <arm_group_label>COPD Patients ~90% VO2max</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>COPD Patients ~90% VO2max</description>
  </arm_group>
  <arm_group>
    <arm_group_label>COPD patients ~60-65% VO2max</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>COPD patients ~60-65% VO2max</description>
  </arm_group>
  <arm_group>
    <arm_group_label>healthy volunteers</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>healthy volunteers</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Muscular biopsy</intervention_name>
    <arm_group_label>COPD Patients ~90% VO2max</arm_group_label>
    <arm_group_label>COPD patients ~60-65% VO2max</arm_group_label>
    <arm_group_label>healthy volunteers</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>5-10 weeks sport training</intervention_name>
    <arm_group_label>healthy volunteers</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  COPD patients :

          -  FEV1&lt;80%pred.

          -  non exacerbation during the past 4 weeks

          -  no oxygen therapy, -

        Healthy subjects:

          -  &lt;150min/week of moderate-to-vigorous physical activity,

          -  Voorrips score &lt;9

        Exclusion Criteria:

          -  Unstable comorbidity

          -  Long term oxygen therapy or ventilation

          -  Rehabilitation program during the past 12 months

          -  nutritional supplementation during the past 4 weeks

          -  allopurinol or N-acetylcystein during the past 4 weeks

          -  long corticosteroid treatment during the past 6 months

          -  hyperreactivity to xylocain

          -  anticoagulant or platelet aggregation inhibitors treatment

          -  participation to an other research study-pregnancy or impossibility to provide
             informed consent, ...
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>78 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Farés Gouzi</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of clinical Physiology - University Hospital</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bronia AYOUB</last_name>
      <phone>+334 67 33 59 10</phone>
      <email>b-ayoub@chu-montpellier.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 16, 2014</lastchanged_date>
  <firstreceived_date>January 10, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>COPD</keyword>
  <keyword>skeletal muscle</keyword>
  <keyword>angiogenesis</keyword>
  <keyword>exercise training</keyword>
  <keyword>intensity</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
